Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
    • Fact Sheets
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations
  • Fact Sheets

OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018

May 2, 2018

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

May 1, 2018

OPKO Health to Remain on the Tel Aviv Stock Exchange

Apr 27, 2018

OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes

Mar 23, 2018

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

Mar 16, 2018

OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

Mar 1, 2018

OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018

Feb 26, 2018

OPKO Health Announces Leadership Changes at BioReference Laboratories

Jan 26, 2018

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center

Jan 12, 2018

OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy

Nov 27, 2017
RSS
  • Prev
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...42
    Next
    © 2021 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap